The ophthalmic drugs contract manufacturing market is estimated to be worth USD 1.7 billion in 2030, predicts Roots Analysis

Outsourcing has become a popular trend among ophthalmic drug developers, allowing them to leverage the expertise / larger production capacities of CMOs / CDMOs and achieve significant cost and time related advantages

Roots Analysis is pleased to announce the publication of its recent study, titled, “Ophthalmic Drugs Contract Manufacturing Market: Focus on Active Pharmaceutical Ingredients and Finished Dosage Forms (Ophthalmic Drops, Emulsions, Gels, Injections, Lotions, Ointments, Suspensions, and Tablets / Capsules), 2020-2030.”

For more information please click on the following link:
https://www.rootsanalysis.com/reports/view_document/ophthalmic-drugs-cmo/294.html

The report features an extensive study of the contract services market for ophthalmic products and solutions. It features in-depth analyses, highlighting the capabilities of a diverse set of CMOs and CDMOs. Amongst other elements, the report includes:
A detailed review of the ophthalmic drugs contract manufacturing market landscape, featuring a list of over 240 CMOs and analysis based on a number of relevant parameters.
A competitiveness analysis of prominent contract manufacturers, featuring insightful pictorial summaries and representations.
Elaborate profiles of key players that offer a diverse range of capabilities for the contract development, manufacturing and packaging of ophthalmic drug products.
A detailed clinical trial analysis of completed, ongoing and planned studies of various ophthalmic drug products.
An estimate of the overall, annual capacity for manufacturing ophthalmic APIs and drug FDFs based on data reported by industry stakeholders in the public domain.
An informed estimate of the annual clinical and commercial demand for ophthalmic APIs and drug FDFs.
A discussion on affiliated trends, key drivers and challenges, under a comprehensive SWOT framework, including a Harvey ball analysis highlighting the relative effect of each SWOT parameter on the overall industry.
A survey analysis featuring inputs solicited from various experts who are directly / indirectly involved in providing contract manufacturing services to ophthalmic drug developers.
A discussion on the emerging trends and potential market drivers, which are likely to impact the evolution of the market in the coming years.
A detailed list of over 55 ophthalmic medical device contract manufacturers, along with information on a number of relevant parameters.

For more information please click on the following link:
https://www.rootsanalysis.com/reports/view_document/ophthalmic-drugs-cmo/294.html

A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
Type of product
Ophthalmic API
Ophthalmic drug FDF

Type of FDF manufactured
Solid
Semi-solid
Liquid / suspension

Type of primary packaging
Ampoule / vial
Glass / plastic bottle
Ointment tube
Blister packing
Other forms

Scale of manufacturing
Clinical
Commercial

Company size
Small
Mid-sized
Large
Very large

Target disease indication
Age-related macular degeneration
Dry eye
Glaucoma
Other disease segments

Key geographical regions
North America (US, Canada and Mexico)
Europe (UK, Germany, France, Spain, Italy and rest of Europe)
Asia-Pacific (India, China, Japan, Australia and rest of Asia-Pacific)
Rest of the world

Key companies covered in the report
Akorn
Akums
Bal Pharma
Catalent
Cayman Chemical
Entod Pharmaceuticals
Farmigea
Glenmark Pharmaceuticals
Indiana Ophthalmics
Lomapharm
Medichem
Pillar5 Pharma
Recipharm
Salvat
Sterling Pharmaceutical Services
Sunways India

For more information please click on the following link:
https://www.rootsanalysis.com/reports/view_document/ophthalmic-drugs-cmo/294.html

Other Recent Offerings
1. China Biopharmaceutical Contract Manufacturing Market, 2020-2030
2. Pharmaceutical Continuous Manufacturing Market, 2020-2030
3. Peptide Therapeutics: Contract API Manufacturing Market, 2020-2030

Contact:
Gaurav Chaudhary
gaurav.chaudhary@rootsanalysis.com

Roots Analysis
A430, 4th Floor,
Bestech Business Towers, Sector 66, Mohali, India
sales@rootsanalysis.com
+1 (415) 800 3415
+44 (122) 391 1091
Web: https://www.rootsanalysis.com/
LinkedIn: https://in.linkedin.com/company/roots-analysis
Twitter: https://twitter.com/RootsAnalysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

This release was published on openPR.